Shopping Cart
- Remove All
- Your shopping cart is currently empty
SARS-CoV-2-IN-32 is a COVID-19 inhibitor. SARS-CoV-2-IN-32 exhibits good binding affinity (-8.8 Kcal/mole) for the COVID-19 major protease (Mpro) (PDB ID: 6LU7) and has anti-proliferative effects on cancer cells. IN-32 can be used to study cancer and COVID-19.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,140 | 6-8 weeks | |
50 mg | $2,785 | 6-8 weeks | |
100 mg | $3,520 | 6-8 weeks |
Description | SARS-CoV-2-IN-32 is a COVID-19 inhibitor. SARS-CoV-2-IN-32 exhibits good binding affinity (-8.8 Kcal/mole) for the COVID-19 major protease (Mpro) (PDB ID: 6LU7) and has anti-proliferative effects on cancer cells. IN-32 can be used to study cancer and COVID-19. |
Molecular Weight | 481.5 |
Formula | C27H23N5O4 |
Cas No. | 96068-42-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.